LINGO1 variants in essential tremor and Parkinson's disease

Acta Neurologica Scandinavica

Volumn 125, Issue 1, 2012, Pages 1-7

  Deng, H ^a   Gu, S ^a   Jankovic, J ^b  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Disease risk; Essential tremor; Genetics; LINGO1; Parkinson's disease; Rs9652490

Indexed keywords

ALLELE; AMINO TERMINAL SEQUENCE; CARBOXY TERMINAL SEQUENCE; CHINA; ESSENTIAL TREMOR; FAMILY HISTORY; FRANCE; GENE; GENE EXPRESSION; GENE FREQUENCY; GENE FUNCTION; GENE LINKAGE DISEQUILIBRIUM; GENE STRUCTURE; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GERMANY; HUMAN; LINGO1 GENE; NONHUMAN; NORTH AMERICA; NORWAY; PARKINSON DISEASE; PATHOGENESIS; POLAND; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; SPAIN; SUBSTANTIA NIGRA;

ESSENTIAL TREMOR; GENE FREQUENCY; GENETIC VARIATION; GENOTYPE; HUMANS; MEMBRANE PROTEINS; NERVE TISSUE PROTEINS; PARKINSON DISEASE;

EID: 84155187234     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/j.1600-0404.2011.01516.x     Document Type: Review

References (67)

1. Louis ED, Thawani SP, Andrews HF. Prevalence of essential tremor in a multiethnic, community-based study in northern Manhattan, New York, NY. Neuroepidemiology 2009;32:208-14.
2. De Rijk MC, Launer LJ, Berger K et al. Prevalence of Parkinson's disease in Europe: a collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology 2000;54:S21-3.
3. Shahed J, Jankovic J. Exploring the relationship between essential tremor and Parkinson's disease. Parkinsonism Relat Disord 2007;13:67-76.
4. Fekete R, Jankovic J. Revisiting the relationship between essential tremor and Parkinson's disease. Mov Disord 2010;25:503-4.
5. Louis ED. Environmental epidemiology of essential tremor. Neuroepidemiology 2008;31:139-49.
6. Skeie GO, Muller B, Haugarvoll K, Larsen JP, Tysnes OB. Differential effect of environmental risk factors on postural instability gait difficulties and tremor dominant Parkinson's disease. Mov Disord 2010;25:1847-52.
7. Deng H, Le W, Jankovic J. Genetics of essential tremor. Brain 2007;130:1456-64.
8. Spanaki C, Plaitakis A. Essential tremor in Parkinson's disease kindreds from a population of similar genetic background. Mov Disord 2009;24:1662-8.
9. Stefansson H, Steinberg S, Petursson H et al. Variant in the sequence of the LINGO1 gene confers risk of essential tremor. Nat Genet 2009;41:277-9.
10. Vilarino-Guell C, Ross OA, Wider C et al. LINGO1 rs9652490 is associated with essential tremor and Parkinson disease. Parkinsonism Relat Disord 2010;16:109-11.
11. Tan EK, Teo YY, Prakash KM et al. LINGO1 variant increases risk of familial essential tremor. Neurology 2009;73:1161-2.
12. Thier S, Lorenz D, Nothnagel M et al. LINGO1 polymorphisms are associated with essential tremor in Europeans. Mov Disord 2010;25:709-15.
13. Vilarino-Guell C, Wider C, Ross OA et al. LINGO1 and LINGO2 variants are associated with essential tremor and Parkinson disease. Neurogenetics 2010;11:401-8.
14. Clark LN, Park N, Kisselev S, Rios E, Lee JH, Louis ED. Replication of the LINGO1 gene association with essential tremor in a North American population. Eur J Hum Genet 2010;18:838-43.
15. Haubenberger D, Hotzy C, Pirker W et al. Role of LINGO1 polymorphisms in Parkinson's Disease. Mov Disord 2009;24:2404-7.
16. Bialecka M, Kurzawski M, Tan EK, Drozdzik M. Analysis of LINGO1 (rs9652490) polymorphism in sporadic Parkinson's disease in a Polish population, and a meta-analysis. Neurosci Lett 2010;472:53-5.
17. Klebe S, Thier S, Lorenz D et al. LINGO1 is not associated with Parkinson's disease in German patients. Am J Med Genet B Neuropsychiatr Genet 2010;153:1173-8.
18. Zuo X, Jiang H, Guo JF et al. Screening for two SNPs of LINGO1 gene in patients with essential tremor or sporadic Parkinson's disease in Chinese population. Neurosci Lett 2010;481:69-72.
19. Guo Y, Jankovic J, Song Z et al. LINGO1 rs9652490 variant in Parkinson disease patients. Neurosci Lett 2011;487:174-6.
20. Wu YR, Tan EK, Chen CM, Kumar PM, Lee-Chen GJ, Chen ST. Genetic analysis of "leucine-rich repeat (LRR) and immunoglobulin (Ig) domain-containing, Nogo receptor-interacting protein-1 (LINGO1)" in two independent Chinese parkinson's disease populations. Am J Med Genet B Neuropsychiatr Genet 2011;156:99-103.
21. Wu YW, Rong TY, Li HH et al. Analysis of Lingo1 variant in sporadic and familial essential tremor among Asians. Acta Neurol Scand 2010. doi:
22. Lorenzo-Betancor O, Samaranch L, Garcia-Martin E et al. LINGO1 gene analysis in Parkinson's disease phenotypes. Mov Disord 2011. doi:
23. Lorenzo-Betancor O, Garcia-Martin E, Cervantes S et al.Lack of association of LINGO1 rs9652490 and rs11856808 SNPs with familial essential tremor. Eur J Neurol 2010. doi:
24. Bourassa CV, Riviere JB, Dion PA et al. LINGO1 variants in the French-Canadian population. PLoS ONE 2011;6:e16254.
25. Gulcher JR, Jonsson P, Kong A et al. Mapping of a familial essential tremor gene, FET1, to chromosome 3q13. Nat Genet 1997;17:84-7.
26. Higgins JJ, Pho LT, Nee LE. A gene (ETM) for essential tremor maps to chromosome 2p22-p25. Mov Disord 1997;12:859-64.
27. Higgins JJ, Loveless JM, Jankovic J, Patel PI. Evidence that a gene for essential tremor maps to chromosome 2p in four families. Mov Disord 1998;13:972-7.
28. Shatunov A, Sambuughin N, Jankovic J et al. Genomewide scans in North American families reveal genetic linkage of essential tremor to a region on chromosome 6p23. Brain 2006;129:2318-31.
29. Deng H, Le WD, Guo Y, Huang MS, Xie WJ, Jankovic J. Extended study of A265G variant of HS1BP3 in essential tremor and Parkinson disease. Neurology 2005;65:651-2.
30. Shatunov A, Jankovic J, Elble R et al. A variant in the HS1-BP3 gene is associated with familial essential tremor. Neurology 2005;65:1995.
31. Deng H, Le WD, Hunter CB, Mejia N, Xie WJ, Jankovic J. A family with Parkinson disease, essential tremor, bell palsy, and parkin mutations. Arch Neurol 2007;64:421-4.
32. Blair MA, Ma S, Phibbs F et al. Reappraisal of the role of the DRD3 gene in essential tremor. Parkinsonism Relat Disord 2008;14:471-5.
33. Lorenz D, Klebe S, Stevanin G et al. Dopamine receptor D3 gene and essential tremor in large series of German, Danish and French patients. Eur J Hum Genet 2009;17:766-73.
34. Bonifati V, Oostra BA, Heutink P. Unraveling the pathogenesis of Parkinson's disease - the contribution of monogenic forms. Cell Mol Life Sci 2004;61:1729-50.
35. Hatano T, Kubo S, Sato S, Hattori N. Pathogenesis of familial Parkinson's disease: new insights based on monogenic forms of Parkinson's disease. J Neurochem 2009;111:1075-93.
36. Xiromerisiou G, Dardiotis E, Tsimourtou V et al. Genetic basis of Parkinson disease. Neurosurg Focus 2010;28:E7.
37. Wintermeyer P, Kruger R, Kuhn W et al. Mutation analysis and association studies of the UCHL1 gene in German Parkinson's disease patients. Neuroreport 2000;11:2079-82.
38. Ross OA, Soto AI, Vilarino-Guell C et al. Genetic variation of Omi/HtrA2 and Parkinson's disease. Parkinsonism Relat Disord 2008;14:539-43.
39. Choi JM, Woo MS, Ma HI et al. Analysis of PARK genes in a Korean cohort of early-onset Parkinson disease. Neurogenetics 2008;9:263-9.
40. Guo Y, Jankovic J, Zhu S et al. GIGYF2 Asn56Ser and Asn457Thr mutations in Parkinson disease patients. Neurosci Lett 2009;454:209-11.
41. Samaranch L, Lorenzo E, Pastor MA et al. Analysis of the GIGYF2 gene in familial and sporadic Parkinson disease in the Spanish population. Eur J Neurol 2010;17:321-5.
42. Guella I, Pistocchi A, Asselta R et al. Mutational screening and zebrafish functional analysis of GIGYF2 as a Parkinson-disease gene. Neurobiol Aging 2010. doi:
43. Carim-Todd L, Escarceller M, Estivill X, Sumoy L. LRRN6A/LERN1 (leucine-rich repeat neuronal protein 1), a novel gene with enriched expression in limbic system and neocortex. Eur J Neurosci 2003;18:3167-82.
44. Chen Y, Aulia S, Li L, Tang BL. AMIGO and friends: an emerging family of brain-enriched, neuronal growth modulating, type I transmembrane proteins with leucine-rich repeats (LRR) and cell adhesion molecule motifs. Brain Res Rev 2006;51:265-74.
45. Mosyak L, Wood A, Dwyer B et al. The structure of the Lingo-1 ectodomain, a module implicated in central nervous system repair inhibition. J Biol Chem 2006;281:36378-90.
46. Llorens F, Gil V, Iraola S et al. Developmental analysis of Lingo-1/Lern1 protein expression in the mouse brain: interaction of its intracellular domain with Myt1l. Dev Neurobiol 2008;68:521-41.
47. Mi S, Lee X, Shao Z et al. LINGO-1 is a component of the Nogo-66 receptor/p75 signaling complex. Nat Neurosci 2004;7:221-8.
48. Zhang Z, Xu X, Zhang Y, Zhou J, Yu Z, He C. LINGO-1 interacts with WNK1 to regulate nogo-induced inhibition of neurite extension. J Biol Chem 2009;284:15717-28.
49. Shao Z, Browning JL, Lee X et al. TAJ/TROY, an orphan TNF receptor family member, binds Nogo-66 receptor 1 and regulates axonal regeneration. Neuron 2005;45:353-9.
50. Wang KC, Kim JA, Sivasankaran R, Segal R, He Z. P75 interacts with the Nogo receptor as a co-receptor for Nogo, MAG and OMgp. Nature 2002;420:74-8.
51. Yamashita T, Tohyama M. The p75 receptor acts as a displacement factor that releases Rho from Rho-GDI. Nat Neurosci 2003;6:461-7.
52. Mi S, Hu B, Hahm K et al. LINGO-1 antagonist promotes spinal cord remyelination and axonal integrity in MOG-induced experimental autoimmune encephalomyelitis. Nat Med 2007;13:1228-33.
53. Lee X, Yang Z, Shao Z et al. NGF regulates the expression of axonal LINGO-1 to inhibit oligodendrocyte differentiation and myelination. J Neurosci 2007;27:220-5.
54. Zhao XH, Jin WL, Wu J, Mi S, Ju G. Inactivation of glycogen synthase kinase-3ß and up-regulation of LINGO-1 are involved in LINGO-1 antagonist regulated survival of cerebellar granular neurons. Cell Mol Neurobiol 2008;28:727-35.
55. Mi S, Miller RH, Lee X et al. LINGO-1 negatively regulates myelination by oligodendrocytes. Nat Neurosci 2005;8:745-51.
56. Mi S, Miller RH, Tang W et al. Promotion of central nervous system remyelination by induced differentiation of oligodendrocyte precursor cells. Ann Neurol 2009;65:304-15.
57. Inoue H, Lin L, Lee X et al. Inhibition of the leucine-rich repeat protein LINGO-1 enhances survival, structure, and function of dopaminergic neurons in Parkinson's disease models. Proc Natl Acad Sci U S A 2007;104:14430-5.
58. Macleod D, Dowman J, Hammond R, Leete T, Inoue K, Abeliovich A. The familial Parkinsonism gene LRRK2 regulates neurite process morphology. Neuron 2006;52:587-93.
59. Paisan-Ruiz C, Jain S, Evans EW et al. Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease. Neuron 2004;44:595-600.
60. Zimprich A, Biskup S, Leitner P et al. Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron 2004;44:601-7.
61. Le W, Chen S, Jankovic J. Etiopathogenesis of Parkinson's disease: a new beginning? Neuroscientist 2009;15:28-35.
62. Raethjen J, Deuschl G. Tremor. Curr Opin Neurol 2009;22:400-5.
63. Tan EK. LINGO1 and Essential Tremor: linking the shakes. Linking LINGO1 to essential tremor. Eur J Hum Genet 2010;18:739-40.
64. Ji B, Li M, Wu WT et al. LINGO-1 antagonist promotes functional recovery and axonal sprouting after spinal cord injury. Mol Cell Neurosci 2006;33:311-20.
65. Lv J, Xu RX, Jiang XD et al. Passive immunization with LINGO-1 polyclonal antiserum afforded neuroprotection and promoted functional recovery in a rat model of spinal cord injury. Neuroimmunomodulation 2010;17:270-8.
66. Satoh J, Tabunoki H, Yamamura T, Arima K, Konno H. TROY and LINGO-1 expression in astrocytes and macrophages/microglia in multiple sclerosis lesions. Neuropathol Appl Neurobiol 2007;33:99-107.
67. Rudick RA, Mi S, Sandrock AW Jr. LINGO-1 antagonists as therapy for multiple sclerosis: in vitro and in vivo evidence. Expert Opin Biol Ther 2008;8:1561-70.